Chapter 29. Anti-norepinephrine therapy against traumatic hemorrhagic necrosis of the spinal cord: preliminary report.
D000818:Animals; D001949:Bretylium Compounds / Q000627:therapeutic use*; D002415:Cats; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004221:Disulfiram / Q000627:therapeutic use*; D006145:Guanethidine / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006892:Hydroxydopamines / Q000627:therapeutic use*; D008750:Methyldopa / Q000627:therapeutic use*; D009336:Necrosis; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use*; D013116:Spinal Cord / Q000473:pathology; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000473:pathology; D013565:Sympatholytics / Q000627:therapeutic use*
D001949:Bretylium Compounds; D006892:Hydroxydopamines; D013565:Sympatholytics; D010643:Phenoxybenzamine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D004221:Disulfiram; D009638:Norepinephrine; D006145:Guanethidine